New study finds effective anti-viral therapies are not widely used among Americans
A national poll recently found that FDA-approved anti-viral therapies Paxlovid and Molnupiravir are not popular among Americans, despite their effectiveness against the COVID-19 virus.
According to the survey, only 11% of infected individuals had been prescribed with the antiviral therapy. …